Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
This locus encodes a nuclear matrix protein. Additionally we are shipping Matrin 3 Kits (10) and Matrin 3 Proteins (4) and many more products for this protein.
Showing 10 out of 72 products:
Human Polyclonal MATR3 Primary Antibody for ICC, IF - ABIN151288
Schessl, Zou, McGrath, Cowling, Maiti, Chin, Sewry, Battini, Hu, Cottle, Rosenblatt, Spruce, Ganguly, Kirschner, Judkins, Golden, Goebel, Muntoni, Flanigan, Mitchell, Bönnemann: Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy. in The Journal of clinical investigation 2008
Show all 10 Pubmed References
Cow (Bovine) Polyclonal MATR3 Primary Antibody for IHC, WB - ABIN2779141
Beausoleil, Jedrychowski, Schwartz, Elias, Villén, Li, Cohn, Cantley, Gygi: Large-scale characterization of HeLa cell nuclear phosphoproteins. in Proceedings of the National Academy of Sciences of the United States of America 2004
Show all 4 Pubmed References
Human Polyclonal MATR3 Primary Antibody for IHC, IHC (p) - ABIN4332843
Johnson, Pioro, Boehringer, Chia, Feit, Renton, Pliner, Abramzon, Marangi, Winborn, Gibbs, Nalls, Morgan, Shoai, Hardy, Pittman, Orrell, Malaspina, Sidle, Fratta, Harms, Baloh, Pestronk, Weihl et al.: Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. ... in Nature neuroscience 2014
Human Polyclonal MATR3 Primary Antibody for ICC, IF - ABIN151103
Dunham-Ems, Lee, Stachowiak, Pudavar, Claus, Prasad, Stachowiak: Fibroblast growth factor receptor-1 (FGFR1) nuclear dynamics reveal a novel mechanism in transcription control. in Molecular biology of the cell 2009
Study demonstrated that overexpression of wild-type Matrin 3 induces profound muscle pathology and motor phenotypes in transgenic mice
A missense mutation in MATR3 was identified in myopathy patients undergoing a needle electromyography.
Our findings indicate that mutations in Matrin 3 that are associated with ALS and myopathy do not dramatically alter the normal localization of the protein or readily induce inclusion formation.
Three-dimensional mapping of the lamin A (show LMNA Antibodies)-matrin-3 interface showed that the LMNA (show LMNA Antibodies) truncating mutation Delta303, which lacks the matrin-3 binding domain, was associated with an increased distance between lamin A (show LMNA Antibodies) and matrin-3.
Suppressing Matrin 3 powers a heightened and broader ZAP (show ZC3HAV1 Antibodies) restriction of HIV-1 gene expression.
MATR3 mutation is identified to be a possible cause of amyotrophic lateral sclerosis.
No mutations were identified, indicating that MATR3 mutations are not a common cause of Amyotrophic lateral sclerosis in Australian familial cases with predominately European ancestry
MATR3 gene disruption is associated with bicuspid aortic valve, aortic coarctation and patent ductus arteriosus.
Mutations in MATR3 are rare in French familial ALS and ALS with FTLD patients.
This study shows a high risk of abnormal respiratory function with progressive worsening in MATR3 myopathy.
Matrin 3 (MATR3) is a novel protein interactor of PABPN1 (show PABPN1 Antibodies). MATR3 together with PABPN1 (show PABPN1 Antibodies) is required for normal paraspeckle function.
Matrin 3 declines significantly in the central nervous system through early development and young adulthood before stabilizing.
Matr3(Gt-ex13) gene trap insertion disturb the polyadenylation of MATR3 transcripts and alter Matrin 3 protein expression.
Matrin 3 interacts specifically with the heat shock proteins glucose-regulated protein 78 (show HSPA5 Antibodies), GRP75 (show HSPA9 Antibodies) and glutathione S-transferase (show GSTa2 Antibodies) pi isoform 2.
This locus encodes a nuclear matrix protein. Mutations at this locus have been associated with distal myopathy 2, which often includes vocal cord and pharyngeal weakness. Alternatively spliced transcript variants, including read-through transcripts with an upstream locus have been described. Related pseuodgenes have been defined on chr1 and chrX.
, matrin 3
, vocal cord and pharyngeal weakness with distal myopathy
, nuclear scaffold protein P130/MAT3